Mechanisms of synergistic action between olaparib and KPT-330 in pancreatic cancer
{{output}}
Background: Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive and prognostically poor cancer driven by multifaceted mechanisms, notably immune evasion and drug resistance. The majority of PDAC patients present with u... ...
